Multicenter, Open-Label, Safety, Tolerability, and Pharmacokinetic Study to Evaluate Single Ascending Doses and Fixed Doses of DVS SR Tablets in the Treatment of Child and Adolescent Outpatients With Major Depressive Disorder.

Trial Profile

Multicenter, Open-Label, Safety, Tolerability, and Pharmacokinetic Study to Evaluate Single Ascending Doses and Fixed Doses of DVS SR Tablets in the Treatment of Child and Adolescent Outpatients With Major Depressive Disorder.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 01 May 2014

At a glance

  • Drugs Desvenlafaxine (Primary)
  • Indications Major depressive disorder
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Pfizer; Wyeth
  • Most Recent Events

    • 11 Jun 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 16 Dec 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 03 Jul 2009 Planned end date (Jan 2010) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top